Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
I feel like a lot of the short termers/ rainbow chasers are gone. Reasons include: Timescales are fairly clear now, people off furlough and back to work as opposed to at home trying to trade shares/make quick money, second waves already happening showing the market isn't going to dissapear. etc.
I think we'll be seeing a lot of blue days going foward.
Iceman, good to see you over here too!
Just doing my very occasional Orph checkin. Not too worried about the short term on this one. Sitting on my hands. Good share IMO, great pipeline and so many possibilites.
Cracking post Ophidian.
It's been the same on this board for weeks. Buzz when there's an RNS, video etc. Couple of days later, impatience returns, the seeds of doubt are sowed again and it all goes downhill again...
Went through at 141, which is of course the days high after close. It's a buy.
Looks favourable. Hopefully mopped up a few shares at the 140 ressistance we've been struggling to break.
Probably the yanks.
Great time to buy awct.
I haven't spoken with anybody who would have the vaccine. It's common knowledge they're trying to rush it through, backed by the Government to save the economy.
That's the biggest problem with the vaccine, getting people to actually have it...
Agreed on all your points PL75. S&S have no doubt been a concern to all of us, but after today I don't feel worried. It's still a potential pitfall but today's video was the next best thing to an RNS.
Approvals will be the biggest value inflection point IMO.
Who else can't wait until they finally get to Awacta themselves?
Wbernard,
That is interesting information, I will be keeping my eyes open.
Avacta and Cytiva seem to have a very high degree of confidence they can do it. Infact, we may be about to find out they're already most of the way there - prototype news in next 5 working days. Not sure if you watched the Cytiva webinar last week where they discussed the challenges faced. If not, you may find it interesting. A lot of it went over my head, but it was very clear that it was no easy task. You seem to have far more knowledge than me.
Most of the way through it sounds like a disaster, but when you get to the end they give assurances they will bring the test to market. The next few days are going to be very interesting indeed! Worth following to see whats going on, even if just out of interest!